Study: RenalGuard Not Superior in Avoiding CIN in High-Risk

A randomized controlled trial showed that RenalGuard is no better than conventional IV hydration at preventing contrast-induced nephropathy in high-risk patients.

Related Keywords

France , Coll Cardiol , Jacque Cartier , York Heart Association , Study Evaluating , Protect Patients , High Risk , Sarah Mauler Wittwer , Institut Cardiovasculaire Paris Sud , New York Heart Association , Transcatheter Aortic Valve Implantation ,